<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00840775</url>
  </required_header>
  <id_info>
    <org_study_id>CV103-01</org_study_id>
    <nct_id>NCT00840775</nct_id>
  </id_info>
  <brief_title>PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)</brief_title>
  <official_title>Clinical Protocol Presillion™ and Presillion™ Plus Stent Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medinol Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medinol Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect and analyze additional information about the safety
      and effectiveness of the Presillion™ Stent System in the treatment of de novo stenotic
      lesions in native coronary arteries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a post market, non-randomized, multi-center, prospective, single arm clinical study
      that will be conducted at up to 25 sites in Europe and Israel. All patients will be followed
      at 30 days, 6 months, 9 months and 1 year post index stenting procedure.

      The primary endpoint will be the incidence of target vessel failure (TVF, see definition
      below) within 270 days of treatment with the Presillion™ Stent System. This rate will be
      compared with a performance goal derived using a meta-analysis of the standard-of-care
      therapy, coronary stenting with bare metal stents. This data will be used to support the PMA
      application for the Presillion™ Stent System.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target vessel failure (TVF)</measure>
    <time_frame>270 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">278</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Presillion™ Stent System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Catheterization, stent deployment</intervention_name>
    <description>Standard catheterization procedure including Bare Metal Stent deployment.</description>
    <arm_group_label>Presillion™ Stent System</arm_group_label>
    <other_name>CoCr Coronary Stent</other_name>
    <other_name>Coronary Stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient &gt;= 18 years old.

          2. Eligible for Percutaneous Coronary Intervention (PCI).

          3. Patient understands the nature of the procedure and provides written informed consent
             prior to the catheterization procedure.

          4. Patient is willing to comply with specified follow-up evaluation and can be contacted
             by telephone.

          5. Acceptable candidate for coronary artery bypass graft (CABG) surgery.

          6. Stable angina pectoris (Canadian Cardiovascular Society (CCS) 1, 2, 3 or 4) or
             unstable angina pectoris (Braunwald Class 1-3, B-C) or a positive functional ischemia
             study (e.g., ETT, SPECT, Stress echocardiography or Cardiac CT).

          7. Male or non-pregnant female patient (Note: females of child bearing potential must
             have a negative pregnancy test prior to enrollment in the study).

        Exclusion Criteria:

          1. Currently enrolled in another investigational device or drug trial that has not
             completed the primary endpoint or that clinically interferes with the current study
             endpoints.

          2. Previously enrolled in another stent trial in the previous 2 years.

          3. ANY planned elective surgery or percutaneous intervention within subsequent 9 months.

          4. A previous coronary interventional procedure of any kind within the 30 days prior to
             the procedure.

          5. The subject requires staged procedure of either the target or any non-target vessel
             within 9 months post-procedure.

          6. Previous drug eluting stent (DES) deployment anywhere in the target vessel.

          7. Any drug eluting stent (DES) deployment anywhere within the past 12 months

          8. Co-morbid condition(s) that could limit the patient's ability to participate in the
             trial or to comply with follow-up requirements, or impact the scientific integrity of
             the trial.

          9. Concurrent medical condition with a life expectancy of less than 12 months.

         10. Known hypersensitivity or contraindication to aspirin, heparin or bivalirudin,
             clopidogrel or ticlopidine, cobalt, nickel, L-605 Cobalt chromium alloy or sensitivity
             to contrast media, which cannot be adequately pre-medicated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ZNA Middelheim</name>
      <address>
        <city>Antwerpen</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Liege</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz-Kreislauf-Zentrum Segeberger Kliniken</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>D-23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVascular Center Frankfurt Sankt Katharinen</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinkum</name>
      <address>
        <city>Siegburg</city>
        <zip>53721</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>D 78050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EMEK Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanz Medical Center, Laniado Hospital</name>
      <address>
        <city>Netanya</city>
        <zip>42150</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Sweden</country>
  </location_countries>
  <removed_countries>
    <country>United Kingdom</country>
  </removed_countries>
  <link>
    <url>http://medinol.com</url>
  </link>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2009</study_first_submitted>
  <study_first_submitted_qc>February 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2009</study_first_posted>
  <last_update_submitted>March 25, 2018</last_update_submitted>
  <last_update_submitted_qc>March 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stent</keyword>
  <keyword>interventional cardiology</keyword>
  <keyword>catheterization</keyword>
  <keyword>symptomatic ischemic heart disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

